Your browser doesn't support javascript.
loading
Levetiracetam vs. phenytoin as 2nd-line treatment for status epilepticus: A systematic review and meta-analysis.
DeMott, Joshua M; Slocum, Giles W; Gottlieb, Michael; Peksa, Gary D.
Afiliação
  • DeMott JM; Department of Pharmacy, Rush University Medical Center, Chicago, IL, USA; Department of Emergency Medicine, Rush University Medical Center, Chicago, IL, USA. Electronic address: Joshua_demott@rush.edu.
  • Slocum GW; Department of Pharmacy, Rush University Medical Center, Chicago, IL, USA; Department of Emergency Medicine, Rush University Medical Center, Chicago, IL, USA.
  • Gottlieb M; Department of Emergency Medicine, Rush University Medical Center, Chicago, IL, USA.
  • Peksa GD; Department of Pharmacy, Rush University Medical Center, Chicago, IL, USA; Department of Emergency Medicine, Rush University Medical Center, Chicago, IL, USA.
Epilepsy Behav ; 111: 107286, 2020 10.
Article em En | MEDLINE | ID: mdl-32707535

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Fenitoína / Estado Epiléptico / Levetiracetam / Anticonvulsivantes Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Fenitoína / Estado Epiléptico / Levetiracetam / Anticonvulsivantes Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article